TY  - JOUR
AU  - Castaño-Bonilla, Tamara
AU  - Alonso-Dominguez, Juan M
AU  - Barragan, Eva
AU  - Rodriguez-Veiga, Rebeca
AU  - Sargas, Claudia
AU  - Gil, Cristina
AU  - Chillon, Carmen
AU  - Vidriales, Maria B
AU  - Garcia, Raimundo
AU  - Martinez-Lopez, Joaquin
AU  - Ayala, Rosa
AU  - Larrayoz, Maria J
AU  - Anguita, Eduardo
AU  - Cuello, Rebeca
AU  - Cantalapiedra, Alberto
AU  - Carrillo, Estrella
AU  - Soria-Saldise, Elena
AU  - Labrador, Jorge
AU  - Recio, Isabel
AU  - Algarra, Lorenzo
AU  - Rodriguez-Medina, Carlos
AU  - Bilbao-Syeiro, Cristina
AU  - Lopez-Lopez, Juan A
AU  - Serrano, Josefina
AU  - De-Cabo, Erik
AU  - Sayas, Maria J
AU  - Olave, Maria T
AU  - Sanchez-Garcia, Joaquin
AU  - Mateos, Mamen
AU  - Blas, Carlos
AU  - Lopez-Lorenzo, Jose L
AU  - Lainez-Gonzalez, Daniel
AU  - Serrano, Juana
AU  - Martinez-Cuadron, David
AU  - Sanz, Miguel A
AU  - Montesinos, Pau
PY  - 2021
DO  - 10.1038/s41598-021-00050-x
UR  - https://hdl.handle.net/10668/28337
T2  - Scientific reports
AB  - FLT3-ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3-ITD allelic ratio has clear prognostic value. Nevertheless, there are numerous manuscripts...
LA  - en
PB  - Nature Publishing Group
KW  - Acute myeloid leukaemia
KW  - Molecular medicine
KW  - Oncogenesis
KW  - Prognostic markers
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Prognosis
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Young Adult
KW  - fms-Like Tyrosine Kinase 3
TI  - Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.
TY  - research article
VL  - 11
ER  -